In gender-specific subgroup analysis, the dose-response RR of MetS incidence per 5 U/l of ALT increment was significantly higher (RR: 1.38, 95% CI: 1.20–1.55) in female populations with lower heterogeneity (I2 = 0.0%, P = 0.780). Here, GPT is linked to metabolic syndrome.